We are live on ! Find out more
ASP

Adams Street Partners Portfolio holdings

AUM $260M
1-Year Est. Return 30.38%
This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+30.38%
3 Year Est. Return
+351.96%
5 Year Est. Return
+202.05%
10 Year Est. Return
+1,159.77%
AUM
$286M
AUM Growth
-$96.2M
Cap. Flow
-$19.3M
Cap. Flow %
-6.75%
Top 10 Hldgs %
98.66%
Holding
22
New
4
Increased
1
Reduced
5
Closed
8

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$25.7M
2
CXM icon
Sprinklr
CXM
+$3.06M
3
FRSH icon
Freshworks
FRSH
+$604K
4
AFRM icon
Affirm
AFRM
+$322K
5
BRZE icon
Braze
BRZE
+$272K

Sector Composition

Rank Sector Weight
1 Technology 65.2%
2 Healthcare 17.9%
3 Consumer Discretionary 10.21%
4 Industrials 6.56%
5 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCTY icon
1
Paylocity
PCTY
$6.97B
$103M 36.08%
568,412
-18,490
-3% -$3.71M
RMNI icon
2
Rimini Street
RMNI
$432M
$51.8M 18.11%
23,565,433
PDD icon
3
Pinduoduo
PDD
$121B
$29.2M 10.21%
+298,150
New +$25.7M
QTWO icon
4
Q2 Holdings
QTWO
$3.64B
$25.1M 8.77%
777,562
MLYS icon
5
Mineralys Therapeutics
MLYS
$2.4B
$21.9M 7.65%
2,302,329
-117,172
-5% -$1.53M
VCSA
6
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$18.8M 6.56%
431,584
-506,641
-54% -$6.16M
ICVX
7
DELISTED
Icosavax, Inc. Common Stock
ICVX
$16.9M 5.9%
2,179,964
-900
-0% -$7.46K
FUSN
8
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$7.66M 2.68%
2,947,809
CRVS icon
9
Corvus Pharmaceuticals
CRVS
$1.09B
$4.78M 1.67%
3,275,616
CXM icon
10
Sprinklr
CXM
$1.42B
$2.96M 1.03%
+214,012
New +$3.06M
PATH icon
11
UiPath
PATH
$6.02B
$1.95M 0.68%
113,954
-241,821
-68% -$4.03M
FRSH icon
12
Freshworks
FRSH
$2.99B
$1.21M 0.42%
60,862
+30,414
+100% +$604K
AFRM icon
13
Affirm
AFRM
$24.5B
$375K 0.13%
+17,610
New +$322K
BRZE icon
14
Braze
BRZE
$2.65B
$289K 0.1%
+6,192
New +$272K
ACLX
15
DELISTED
Arcellx
ACLX
-22,924
Closed -$725K
CFLT
16
DELISTED
Confluent
CFLT
-213,798
Closed -$7.55M
FLYW icon
17
Flywire
FLYW
$1.99B
-147,336
Closed -$4.57M
HOOD icon
18
Robinhood
HOOD
$85.9B
-482,220
Closed -$4.81M
IOT icon
19
Samsara
IOT
$20.6B
-36,681
Closed -$1.02M
MIRM icon
20
Mirum Pharmaceuticals
MIRM
$6.96B
-29,849
Closed -$772K
PGNY icon
21
Progyny
PGNY
$2.47B
-29,858
Closed -$1.17M
GTM
22
ZoomInfo Technologies
GTM
$908M
-520,631
Closed -$13.2M

Similar funds

Adams Street Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Adams Street Partners held 22 positions worth $286M, down 25% from $382M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Adams Street Partners withdrew a net $19.3M in Q3 2023, closing 8 positions and reducing 5 holdings. Its most notable exit was ZoomInfo Technologies, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 65% of assets, down from 73% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Adams Street Partners opened a new position in Pinduoduo worth $29.2M.

  • Adams Street Partners's largest Q3 2023 buy was Pinduoduo: 298,150 shares worth $29.2M.
  • Adams Street Partners added most to Freshworks in Q3 2023, an estimated $604K increase.
  • Adams Street Partners's biggest Q3 2023 reduction was Vacasa, Inc. Class A Common Stock, cutting an estimated $6.16M.
  • Adams Street Partners fully exited ZoomInfo Technologies in Q3 2023, selling an estimated $13.2M.
  • Adams Street Partners's ten largest holdings make up 99% of its $286M portfolio in Q3 2023.
  • Adams Street Partners opened 4 new positions and closed 8 in Q3 2023.
  • Adams Street Partners's portfolio value fell 25% quarter-over-quarter to $286M.

Based on Adams Street Partners's 13F filing for Q3 2023, filed 14 Nov 2023.